Oxford Nanopore
Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has around 900 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecules.
JP Morgan Healthcare Conference, Day 1: Oxford Nanopore, 10x Genomics, Bruker, Qiagen, More
Highlights from the first day included Exact Sciences' plan to launch three new cancer tests in 2025 and Qiagen's sample prep launch plans for 2026.
Preliminary Earnings Roundup: Oxford Nanopore, 10x Genomics, Bionano Genomics, Standard BioTools
Several tools firms reported fourth quarter and full-year 2024 revenues and other business updates ahead of the annual JP Morgan Healthcare Conference this week.
Both short-read and long-read instrument makers are fleshing out their multiomics menus as they hope to gain a share of the fast-evolving market.
Top Five Articles on GenomeWeb Last Week: Colorado Genetic Testing Lawsuit, Pleno Financing, More
Last week, GenomeWeb's readers were most interested in news about an ongoing lawsuit in Colorado claiming negligence against a hospital and GeneDx.
Oxford Nanopore Technologies Sues BGI, Affiliates for Sequencing Technology Contract Breach
Among other demands, Oxford Nanopore asked the UK court to grant an injunction to prevent the sale and licensing of BGI's nanopore sequencing products.